glp 1 water retention Proposed mechanism of GLP-1 RA impact on sodium and homeostasis Hydration on GLP-1s: Preventing Side

Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrom...

Blocks the kidney protein that pulls glucose back into your blood, helping excrete sugar

GLP-1s are reshaping in weight management, but GI side effects can derail outcomes.

Among emerging anti-diabetic candidates, glucagon like peptide-1 (GLP-1) based therapies carry special cardiovascular implications, exerting both direct as well as indirect effects

Novo Nordisk's Wegovy pill expands obesity drug market Novo Nordisk's oral GLP-1 treatment, the Wegovy pill, has seen high demand since its January launch, attracting patients who previously avoided injections due to needle fear or high costs